January 2025 Price Concessions 3rd Update

THIS CONTENT HAS NOW EXPIRED

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (21/01/2025) announced the following list of price concessions for January 2025:

Drug Pack size Price concession
Benzydamine 0.15% mouthwash sugar free 300 £4.65
Cefalexin 500mg tablets 21 £2.99
Chloramphenicol 0.5% eye drops 10 £4.60
Clotrimazole 500mg pessary and Clotrimazole 2% cream 1 £6.30
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.65
Desmopressin 120microgram sublingual tablets sugar free 30 £23.35
Flucloxacillin 500mg capsules 28 £2.78
Isosorbide mononitrate 20mg tablets 56 £3.84
Naftidrofuryl 100mg capsules 84 £10.80
Olanzapine 20mg tablets 28 £3.23
Olanzapine 5mg orodispersible tablets sugar free 28 £6.00
Oxybutynin 5mg tablets 56 £1.50
Perindopril erbumine 8mg tablets 30 £2.07
Pregabalin 100mg capsules 84 £2.29
Propantheline bromide 15mg tablets 112 £103.52
Ramipril 2.5mg tablets 28 £1.22
Telmisartan 40mg tablets 28 £5.36
Travoprost 40micrograms/ml / timolol 5mg/ml eye drops 2.5 £13.95

For the full list of price concessions granted for January 2025 so far please visit our price concession hub page here.

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Improvements to the price concession system

Following significant concerns raised by pharmacy owners about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacy owners cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process in 2023, a package of measures has been developed to improve the system. These include:

  • all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession
  • any agreed prices for concessions requested on or after the 23rd of the month will be rolled over to the following month
  • a retrospective increased payment system for price concession lines where data subsequently identifies that the original price concessions granted were inappropriately low. Further information regarding this concession ‘top-up’ mechanism can be found here.

Please see our latest funding and reimbursement short video for further information on all the recent changes to the price concession process.